Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0KVVLW
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
mAb-P5 (PEG12)- VC-PAB-Exatecan
|
|||||
| Synonyms |
mAb-P5 (PEG12)- VC-PAB-Exatecan
Click to Show/Hide
|
|||||
| Organization |
TUBULIS GMBH
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
0-20
|
|||||
| Structure |
|
|||||
| Antibody Name |
AV-25
|
Antibody Info | ||||
| Antigen Name |
N-myc downstream-regulated gene 2B (NDRG2B)
|
Antigen Info | ||||
| Payload Name |
Exatecan
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 1 (TOP1)
|
Target Info | ||||
| Linker Name |
P5 (PEG12)- VC-PAB linker
|
Linker Info | ||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||
| Combination Type |
P5 (PEG12)- VC-PAB-Exatecan
|
|||||